We are pleased to invite you to attend our next 30 minute webinar session, taking place at 9am on Wednesday 01st December 2021, with guest panellists Savvas Neophytou, Partner & Head of Life Sciences, and Adrian Neilan, COO & Technology Investment Director.
We are in unprecedented times, but we believe our investment style of providing hands-on support to investee companies will stand us in good stead and has never been more important.
Nevertheless, please be reminded that any investment into an unquoted early stage company should be considered as high risk.
The views expressed in this broadcast are the views of the individual and not necessarily of Deepbridge Capital LLP. Figures quoted by the presenter and/or guest may be approximations.
The content of this video should not be construed as financial advice.
This video is a real-time financial promotion and, as a result, has not been approved as a financial promotion for the purposes of Section 21 of the Financial Services and Markets Act 2000.
Any decision to invest should be made only on the basis of the relevant documentation for the investment available in the accompanying company profile. Investments in unquoted companies carry high risks.
Capital invested will be at risk and you could lose all of your investment. No established market exists for the trading of shares in private companies, making it difficult to sell shares.
Tax treatment depends on the individual circumstances of each investor and may be subject to change in future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status.
Past performance is not a reliable indicator of future performance.